NL – Carl Zeiss v. VSY

Posted: June 9th, 2017

Carl Zeiss Meditec AG v. VSY Biotechnology B.V. et al., District Court The Hague, The Netherlands, 7 June 2017, Case No. ECLI:NL:RBDHA:2017:6136 European Patent on an intraocular (implantable) lens. Interpretation of claims. The Dutch part of the patent is valid: the hurdles of novelty, inventive step and enablement were all taken successfully. The patent is […]


NL – Sun v. Novartis / Supreme Court

Posted: May 8th, 2017

Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Supreme Court of the Netherlands, 14 April 2017, Case No. ECLI:NL:HR:2017:692 Preliminary injunction proceedings. Patent for second medical indication. Swiss-type claim. Novartis owns EP 1 296 689 with a Swiss type claim for use of zoledronic acid in the preparation of a medicament for the treatment of […]


HU – PI prevents Pharmaceutical Product launch

Posted: March 14th, 2017

Budapest Court Grants Preliminary Injunction Based on Direct Threat of Patent Infringement Preventing Pharmaceutical Product Launch The Metropolitan Court, Budapest has recently issued an order granting preliminary injunction against a Hungarian pharmaceutical distributor. The specialty of the case is that the allegedly infringing pharmaceutical product was not yet launched and it is the first time […]


NL – Eli Lilly v. Sandoz

Posted: March 6th, 2017

Eli Lilly Company v. Sandoz B.V., District Court the Hague, 1 March 2017, Case No. ECLI:NL:RBDHA:2017:1907 Preliminary injunction proceedings. It is unlikely that the patent will be revoked in proceedings on the merits. No implicit disclosure of the administering of vitamine B12. Injunction granted. A copy of the judgment can be read here.


FR – Warner-Lambert & Pfizer v. generics / Pregabalin PI

Posted: January 20th, 2017

Pregabalin PI in France: a decision dealing with skinny label, second medical use claims and contributory infringement A new pregabalin decision has been rendered on December 2, 2016 in France, in a PI litigation initiated by Warner-Lambert (hereafter: the patentee) and licensees Pfizer against 9 groups of generic companies (hereafter: the defendants). All defendants are […]


NL – DSM v. Novozymes

Posted: January 11th, 2017

DSM IP Assets B.V. v. Novozymes A/S, PI Judge of the District Court of The Hague, The Netherlands, 6 January 2017, Case No. ECLI:NL:RBDHA:2017:110 DSM holps a patent entitled ‘Enzyme preparation yielding a clean taste’. During Opposition, the patent was limited to milk sterilised at ultra high temperatures (‘UHT milk’). An appeal at the TBA […]


ES – Abbott v. Kern / Fenofibrate 145 (Interim injunction appeal)

Posted: November 15th, 2016

Abbott Products Operations AG v. Kern Pharma S.L., Court of Appeals (15th Division) of Barcelona, Spain, 15 September 2016, Docket No. 163/2016. In a Decision rendered on 15 September 2016, the Court of Appeals of Barcelona granted the interim injunctions requested by Abbott against Kern Pharma’s generic Fenofibrate 145 mg. The Court reversed the previous […]


NL – AstraZeneca v. Sandoz / FASLODEX

Posted: August 1st, 2016

Astrazeneca AB v. Sandoz B.V., PI judge of the District Court of The Hague, 27 July 2016, Case No. ECLI:NL:RBDHA:2016:8700 There is too much doubt that Claim 1 of the Patent in suit will be declared invalid in proceedings on the merits due to lack of inventive step. The requested preliminary injunction therefore will be […]


NL – Basic Holdings v. Ruby Decor

Posted: June 21st, 2016

* Now including an English translation of the judgment * Basic Holdings ULC v. Ruby Decor B.V., Aparto B.V., District Court The Hague, The Netherlands, 4 May 2016, ECLI:NL:RBDHA:2016:4657, with thanks to Alexander Tsoutsanis, DLA Piper (NL) for sending in the English translation Basic Holdings, part of the Glen Dimplex Group, is proprietor of EP […]